| 04 Feb, 02:38 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 04, 2026, titled "Zydus receives tentative approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg". | nse |
| 31 Jan, 06:29 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about change in Management | nse |
| 31 Jan, 06:25 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 27 Jan, 04:42 pm | — | … | Zydus Lifesciences Ltd - 532321 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter / Nine Months Ended On December 31, 2025. | bse |
| 23 Jan, 05:45 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 23, 2026, titled "Outcome of USFDA inspection". | nse |
| 23 Jan, 05:42 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 22 Jan, 09:54 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 22 Jan, 09:51 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 22, 2026, titled "Zydus launches the world s first biosimilar of Nivolumab, Tishtha , in India to treat multiple cancers". | nse |
| 20 Jan, 10:36 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding 'Revision in ESG Rating'. | nse |
| 17 Jan, 05:54 pm | — | … | Zydus Lifesciences Ltd - 532321 - Update | bse |
| 17 Jan, 05:51 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 15 Jan, 05:30 pm | — | … | Zydus Lifesciences Ltd - 532321 - Closing Of Acquisition | bse |
| 15 Jan, 05:28 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 15 Jan, 01:16 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 15, 2026, titled "Zydus receives final approval from USFDA for Eltrombopag Tablets,12.5 mg, 25 mg, 50 mg, and 75 mg". | nse |
| 15 Jan, 01:14 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 Jan, 10:04 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 Jan, 10:01 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 13, 2026, titled "Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO® (copper histidinate)". | nse |
| 10 Jan, 02:16 pm | — | … | Zydus Lifesciences Ltd - 532321 - Update | bse |
| 10 Jan, 02:11 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 02 Jan, 02:43 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 30 Dec, 06:29 pm | — | … | Zydus Lifesciences Ltd - 532321 - Receipt Of Demand Order-In-Original From Assistant Commissioner Of State Tax, Gujarat | bse |
| 30 Dec, 06:25 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 26 Dec, 07:12 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding 'Intimation of ESG Rating'. | nse |
| 24 Dec, 05:57 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 24 Dec, 05:55 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 23 Dec, 06:28 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 23 Dec, 06:28 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 23, 2025, titled "Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®. NUFYMCO®. BLA has been approved by the USFDA". | nse |
| 19 Dec, 09:52 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 19 Dec, 09:49 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 19, 2025, titled "Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India". | nse |
| 16 Dec, 05:22 pm | — | … | Zydus Lifesciences Ltd - 532321 - Intimation Of ESG Rating | bse |
| 16 Dec, 05:19 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 15 Dec, 06:30 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 15 Dec, 06:30 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 15, 2025, titled "Sentynl Therapeutics Announces FDA Acceptance of CUTX-101 NDA Resubmission". | nse |
| 10 Dec, 10:18 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Dec, 10:14 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 10, 2025, titled "Zydus launches biosimilar Denosumab 120 mg SC protecting bone health in cancer patients". | nse |
| 09 Dec, 05:31 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 09 Dec, 05:30 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 09, 2025, titled "Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada". | nse |
| 04 Dec, 12:47 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 04 Dec, 12:45 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 04, 2025, titled "Zydus receives EIR for the injectable facility located at Jarod". | nse |
| 27 Nov, 04:31 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 27 Nov, 04:28 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 27, 2025, titled "Zydus receives tentative approval from USFDA for Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg". | nse |
| 26 Nov, 12:27 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 26 Nov, 12:24 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 26, 2025, titled "Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market.". | nse |
| 25 Nov, 03:58 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 25 Nov, 03:54 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 25, 2025, titled "Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg". | nse |
| 25 Nov, 11:19 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 25 Nov, 11:16 am | — | … | Zydus Lifesciences Limited has informed the Exchange about Investor Presentation | nse |
| 19 Nov, 04:41 pm | — | … | Zydus Lifesciences Ltd - 532321 - General Update | bse |
| 19 Nov, 04:36 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 17 Nov, 06:58 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding 'Disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015'. | nse |